SUMMARY Plasma exchange (PE) is indicated in adult patients with a severe Guillain-Barre syndrome (GBS). For children this has not been proven. If the disease runs a milder course in children, the problems experienced with PE might outweigh the benefit. In order to evaluate the need for such a specific treatment in children, we compared the severity of the disease between 18 children and 50 adults; no significant differences were found. The mean duration of hospitalisation of all children was 84 days, four children needed artificial ventilation for a mean of 21-5 days and two children died. We conclude therefore that PE is indicated in children with a severe GBS. The final decision, however, depends also on the practical feasibility of the procedure.
The Guillain Barre syndrome (GBS) is a monophasic polyneuropathy from which many patients ultimately recover satisfactorily. However, artificial respiration is necessary in 10-20% of the patients in the acute phase of the disease, 10-22% finally remain disabled and there is a mortality of 3-5%.'3 For these reasons, an effective treatment has been sought and at present plasma exchange (PE) is generally accepted as such, early in the course of the GBS. 4 In all trials leading to the acceptance of PE, children were excluded."7 Although the effect of PE in children is not really known, there is no reason to assume that it would not be effective. Case studies have shown that treatment related improvement does occur in children8 (one of three cases has recently been published9).
The practical problems ofPE, however, especially in small children, make us reluctant to apply this treatment. Moreover, it has been suggested that the outcome of GBS in children might be more favourable,'0 making such a specific treatment unnecessary.
To enable us to take the clinical decision about treatment with PE in children, it seems necessary to have more knowledge about the natural history of the GBS In the final analysis, the patients were split into two groups: patients who had made a good recovery (0/1) and patients who had a residual handicap or had died (grades 2-6). The great majority of the information was available in the medical records: sometimes the general practitioner was consulted in order to complete the follow-up data.
Results
In the 18 children studied the age varied between 1 heart rate and blood pressure. One other child, a 10 year old boy, had not made a good recovery within two years; he was in functional group 2. In the adult group, four patients were found to have made an incomplete recovery after two years; one was confined to a wheelchair (38 years) and three were in functional group 2 (23, 39 and 46 years respectively). When patients in grade 2-6 are considered together, three (17%) children had not recovered completely after 2 years (this included two deaths), versus four (8%) adult patients (table 4) .
Discussion
Using artificial ventilation, length of hospitalisation and functional outcome after one and two years as parameters for the severity of the disease, we have not been able to demonstrate statistically significant differences between 18 children and 50 adults. The 95% confidence limits are, however, rather large reflecting the relatively small number of patients. Therefore no definite conclusions regarding the similarity of the two groups can be drawn; in fact, either group may be more severely affected. Recently it has been demonstrated that the prognosis is worse for adults over 40 years of age'5 compared with younger adults. It might thus be reasonable to consider children and adults under 40 years of age as a single group having a better prognosis than the older patients. It has recently been shown that the duration of the 
The natural history of the Guillain-Barre' syndrome in 18 children and 50 adults Although plasma exchange has proved its beneficial effects in clinical trials performed exclusively in adults, there is no reason to believe that it would be less effective in children. Case reports, including our own observations89 suggest beneficial effects. Plasma exchange, however, is a cumbersome procedure with practical difficulties especially in smaller children. It should therefore be reserved for more severely affected children, in whom the beneficial effect of PE will outweigh the technical difficulties.
In the near future, high dose immunoglobulins might be an alternative, even for the smallest children. Recently, we described the promising experience with this treatment in eight GBS patients, including one 11 year old child.9 Application of this treatment must, however, await the results of the ongoing Dutch multicentre trial, (in which children are also included) to compare the effect ofplasma exchange with immunoglobulin infusion.
